Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function.

de Winter-de Groot KM, Janssens HM, van Uum RT, Dekkers JF, Berkers G, Vonk A, Kruisselbrink E, Oppelaar H, Vries R, Clevers H, Houwen RHJ, Escher JC, Elias SG, de Jonge HR, de Rijke YB, Tiddens HAWM, van der Ent CK, Beekman JM.

Eur Respir J. 2018 Sep 17;52(3). pii: 1702529. doi: 10.1183/13993003.02529-2017. Print 2018 Sep.

PMID:
30166324
2.

Editorial: anxiety and depression in inflammatory bowel disease - authors' reply.

Stapersma L, van den Brink G, Szigethy EM, Escher JC, Utens EMWJ.

Aliment Pharmacol Ther. 2018 Sep;48(6):687-688. doi: 10.1111/apt.14928. No abstract available.

PMID:
30132944
3.

Frequencies of circulating regulatory TIGIT+CD38+ effector T cells correlate with the course of inflammatory bowel disease.

Joosse ME, Menckeberg CL, de Ruiter LF, Raatgeep HRC, van Berkel LA, Simons-Oosterhuis Y, Tindemans I, Muskens AFM, Hendriks RW, Hoogenboezem RM, Cupedo T, de Ridder L, Escher JC, Veenbergen S, Samsom JN.

Mucosal Immunol. 2018 Aug 20. doi: 10.1038/s41385-018-0078-4. [Epub ahead of print]

PMID:
30127383
4.

Systematic review with meta-analysis: anxiety and depression in children and adolescents with inflammatory bowel disease.

Stapersma L, van den Brink G, Szigethy EM, Escher JC, Utens EMWJ.

Aliment Pharmacol Ther. 2018 Sep;48(5):496-506. doi: 10.1111/apt.14865. Epub 2018 Jul 8. Review.

PMID:
29984495
5.

Self-efficacy did not predict the outcome of the transition to adult care in adolescents with inflammatory bowel disease.

van den Brink G, van Gaalen MAC, Zijlstra M, de Ridder L, van der Woude CJ, Escher JC.

Acta Paediatr. 2018 Jun 21. doi: 10.1111/apa.14471. [Epub ahead of print]

PMID:
29926962
6.

Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease.

van den Brink G, Stapersma L, Vlug LE, Rizopolous D, Bodelier AG, van Wering H, Hurkmans PCWM, Stuyt RJL, Hendriks DM, van der Burg JAT, Utens EMWJ, Escher JC.

Aliment Pharmacol Ther. 2018 Aug;48(3):358-369. doi: 10.1111/apt.14832. Epub 2018 Jun 13.

PMID:
29897134
7.

Weibel-Palade Body Localized Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells.

Schillemans M, Karampini E, van den Eshof BL, Gangaev A, Hofman M, van Breevoort D, Meems H, Janssen H, Mulder AA, Jost CR, Escher JC, Adam R, Carter T, Koster AJ, van den Biggelaar M, Voorberg J, Bierings R.

Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1549-1561. doi: 10.1161/ATVBAHA.117.310701. Epub 2018 Jun 7.

8.

Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.

Stapersma L, van den Brink G, van der Ende J, Szigethy EM, Beukers R, Korpershoek TA, Theuns-Valks SDM, Hillegers MHJ, Escher JC, Utens EMWJ.

J Pediatr Psychol. 2018 May 29. doi: 10.1093/jpepsy/jsy029. [Epub ahead of print]

PMID:
29850915
9.

Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero.

de Lima A, Kanis SL, Escher JC, van der Woude CJ.

J Crohns Colitis. 2018 Jul 30;12(8):948-953. doi: 10.1093/ecco-jcc/jjy053.

PMID:
29726943
10.

The impact of Narcotrend™ EEG-guided propofol administration on the speed of recovery from pediatric procedural sedation-A randomized controlled trial.

Weber F, Walhout LC, Escher JC.

Paediatr Anaesth. 2018 May;28(5):443-449. doi: 10.1111/pan.13365. Epub 2018 Mar 25.

PMID:
29575232
11.

Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition.

Miele E, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, de Ridder L, Escher JC, Hojsak I, Kolaček S, Koletzko S, Levine A, Lionetti P, Martinelli M, Ruemmele F, Russell RK, Boneh RS, van Limbergen J, Veereman G, Staiano A.

J Pediatr Gastroenterol Nutr. 2018 Apr;66(4):687-708. doi: 10.1097/MPG.0000000000001896.

PMID:
29570147
12.

Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.

Ledder O, Assa A, Levine A, Escher JC, de Ridder L, Ruemmele F, Shah N, Shaoul R, Wolters VM, Rodrigues A, Uhlig HH, Posovszky C, Kolho KL, Jakobsen C, Cohen S, Shouval DS, de Meij T, Martin-de-Carpi J, Richmond L, Bronsky J, Friedman M, Turner D.

J Crohns Colitis. 2018 Apr 27;12(5):630. doi: 10.1093/ecco-jcc/jjx172. No abstract available.

PMID:
29562246
13.

Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn's disease : a randomised controlled trial.

Levine A, Kori M, Kierkus J, Sigall Boneh R, Sladek M, Escher JC, Wine E, Yerushalmi B, Amil Dias J, Shaoul R, Veereman Wauters G, Boaz M, Abitbol G, Bousvaros A, Turner D.

Gut. 2018 Feb 2. pii: gutjnl-2017-315199. doi: 10.1136/gutjnl-2017-315199. [Epub ahead of print]

PMID:
29420227
14.

Nutrition in Paediatric Inflammatory Bowel Disease: A Position Paper on Behalf of The Porto IBD Group of ESPGHAN.

Miele E, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, de Ridder L, Escher JC, Hojsak I, Kolaček S, Koletzko S, Levine A, Lionetti P, Martinelli M, Ruemmele F, Russell RK, Boneh RS, van Limbergen J, Veereman G, Staiano A.

J Pediatr Gastroenterol Nutr. 2018 Jan 29. doi: 10.1097/MPG.0000000000001896. [Epub ahead of print]

PMID:
29384890
15.

Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care.

Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, Escher JC, Walhout LC, Kindermann A, de Rijke YB, van Rheenen PF, Berger MY.

PLoS One. 2017 Dec 6;12(12):e0189111. doi: 10.1371/journal.pone.0189111. eCollection 2017.

16.

Less Anti-infliximab Antibody Formation in Paediatric Crohn Patients on Concomitant Immunomodulators.

Kansen HM, van Rheenen PF, Houwen RHJ, Tjon A Ten W, Damen GM, Kindermann A, Escher JC, Wolters VM; Kids with Crohnʼs, Colitis (KiCC) Working Group for Collaborative Paediatric IBD Research in the Netherlands.

J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):425-429. doi: 10.1097/MPG.0000000000001551.

PMID:
28945207
17.

Disrupted apical exocytosis of cargo vesicles causes enteropathy in FHL5 patients with Munc18-2 mutations.

Vogel GF, van Rijn JM, Krainer IM, Janecke AR, Posovszky C, Cohen M, Searle C, Jantchou P, Escher JC, Patey N, Cutz E, Müller T, Middendorp S, Hess MW, Huber LA.

JCI Insight. 2017 Jul 20;2(14). pii: 94564. doi: 10.1172/jci.insight.94564. [Epub ahead of print]

18.

Development and Function of Immune Cells in an Adolescent Patient With a Deficiency in the Interleukin-10 Receptor.

Veenbergen S, van Leeuwen MA, Driessen GJ, Kersseboom R, de Ruiter LF, Raatgeep RHC, Lindenbergh-Kortleve DJ, Simons-Oosterhuis Y, Biermann K, Halley DJJ, de Ridder L, Escher JC, Samsom JN.

J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):e5-e15. doi: 10.1097/MPG.0000000000001559.

PMID:
28644354
19.

Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.

Ledder O, Assa A, Levine A, Escher JC, de Ridder L, Ruemmele F, Shah N, Shaoul R, Wolters VM, Rodrigues A, Uhlig HH, Posovsky C, Kolho KL, Jakobsen C, Cohen S, Shouval DS, de Meij T, Martin-de-Carpi J, Richmond L, Bronsky J, Friedman M, Turner D.

J Crohns Colitis. 2017 Oct 1;11(10):1230-1237. doi: 10.1093/ecco-jcc/jjx082.

PMID:
28605483
20.

Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN.

Birimberg-Schwartz L, Zucker DM, Akriv A, Cucchiara S, Cameron FL, Wilson DC, Lazowska I, Yianni L, Paul SP, Romano C, Kolacek S, Buderus S, Pærregaard A, Russell RK, Escher JC, Turner D; Pediatric IBD Porto group of ESPGHAN.

J Crohns Colitis. 2017 Sep 1;11(9):1078-1084. doi: 10.1093/ecco-jcc/jjx053.

PMID:
28430891
21.

European Crohn's and Colitis Organisation Topical Review on Transitional Care in Inflammatory Bowel Disease.

van Rheenen PF, Aloi M, Biron IA, Carlsen K, Cooney R, Cucchiara S, Cullen G, Escher JC, Kierkus J, Lindsay JO, Roma E, Russell RK, Sieczkowska-Golub J, Harbord M.

J Crohns Colitis. 2017 Sep 1;11(9):1032-1038. doi: 10.1093/ecco-jcc/jjx010.

PMID:
28158494
22.

Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial.

Cozijnsen MA, van Pieterson M, Samsom JN, Escher JC, de Ridder L.

BMJ Open Gastroenterol. 2016 Dec 22;3(1):e000123. doi: 10.1136/bmjgast-2016-000123. eCollection 2016.

23.

Taurolidine in Pediatric Home Parenteral Nutrition Patients.

Hulshof EC, Hanff LM, Olieman J, de Vette S, Driessen GJ, Meeussen C, Escher JC.

Pediatr Infect Dis J. 2017 Feb;36(2):233-235. doi: 10.1097/INF.0000000000001404.

PMID:
27846059
24.

Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.

Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, Escher JC, Kindermann A, de Rijke YB, van Rheenen PF, Berger MY.

Ann Fam Med. 2016 Sep;14(5):437-45. doi: 10.1370/afm.1949.

25.

[Transition from paediatric to adult care: management of adolescents with inflammatory bowel disease].

van den Brink G, van der Woude CJ, de Ridder L, van Gaalen MA, Escher JC.

Ned Tijdschr Geneeskd. 2016;160:D578. Dutch.

PMID:
27581867
26.

Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms.

Holtman GA, Lisman-van Leeuwen Y, van Rheenen PF, Kollen BJ, Escher JC, Kindermann A, de Rijke YB, Berger MY.

Fam Pract. 2017 Aug 1;34(4):400-406. doi: 10.1093/fampra/cmw079.

PMID:
27535331
27.

Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis.

Dekkers JF, Berkers G, Kruisselbrink E, Vonk A, de Jonge HR, Janssens HM, Bronsveld I, van de Graaf EA, Nieuwenhuis EE, Houwen RH, Vleggaar FP, Escher JC, de Rijke YB, Majoor CJ, Heijerman HG, de Winter-de Groot KM, Clevers H, van der Ent CK, Beekman JM.

Sci Transl Med. 2016 Jun 22;8(344):344ra84. doi: 10.1126/scitranslmed.aad8278.

PMID:
27334259
28.

pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.

Birimberg-Schwartz L, Wilson DC, Kolho KL, Karolewska-Bochenek K, Afzal NA, Spray C, Romano C, Lionetti P, Hauer AC, Martinez-Vinson C, Veres G, Escher JC, Turner D; paediatric IBD Porto group of ESPGHAN.

Inflamm Bowel Dis. 2016 Aug;22(8):1908-14. doi: 10.1097/MIB.0000000000000784.

PMID:
27135480
29.

Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD).

van den Brink G, Stapersma L, El Marroun H, Henrichs J, Szigethy EM, Utens EM, Escher JC.

BMJ Open Gastroenterol. 2016 Mar 2;3(1):e000071. doi: 10.1136/bmjgast-2015-000071. eCollection 2016.

30.

Herpesvirus Infections and Transglutaminase Type 2 Antibody Positivity in Childhood: The Generation R Study.

Jansen MA, van den Heuvel D, van der Zwet KV, Jaddoe VW, Hofman A, Escher JC, Fraaij PL, Hooijkaas H, van Zelm MC, Moll HA.

J Pediatr Gastroenterol Nutr. 2016 Oct;63(4):423-30. doi: 10.1097/MPG.0000000000001163.

PMID:
26881413
31.

More Target, More Treatment.

Escher JC.

J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):796-7. doi: 10.1097/MPG.0000000000001051. No abstract available.

PMID:
26628443
32.

The Role of Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Alpha Agents in Children and Adolescents with Inflammatory Bowel Disease.

Joosse ME, Samsom JN, van der Woude CJ, Escher JC, van Gelder T.

Inflamm Bowel Dis. 2015 Sep;21(9):2214-21. doi: 10.1097/MIB.0000000000000420. Review.

PMID:
26284297
33.

Pediatric IBD-unclassified Is Less Common than Previously Reported; Results of an 8-Year Audit of the EUROKIDS Registry.

Winter DA, Karolewska-Bochenek K, Lazowska-Przeorek I, Lionetti P, Mearin ML, Chong SK, Roma-Giannikou E, Maly J, Kolho KL, Shaoul R, Staiano A, Damen GM, de Meij T, Hendriks D, George EK, Turner D, Escher JC; Paediatric IBD Porto Group of ESPGHAN.

Inflamm Bowel Dis. 2015 Sep;21(9):2145-53. doi: 10.1097/MIB.0000000000000483.

PMID:
26164665
34.

Loss of ADAM17 is associated with severe multiorgan dysfunction.

Bandsma RH, van Goor H, Yourshaw M, Horlings RK, Jonkman MF, Schölvinck EH, Karrenbeld A, Scheenstra R, Kömhoff M, Rump P, Koopman-Keemink Y, Nelson SF, Escher JC, Cutz E, Martín MG.

Hum Pathol. 2015 Jun;46(6):923-8. doi: 10.1016/j.humpath.2015.02.010. Epub 2015 Mar 5.

35.

Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease.

Cozijnsen MA, Escher JC, Griffiths A, Turner D, de Ridder L.

Inflamm Bowel Dis. 2015 Apr;21(4):951-61. doi: 10.1097/MIB.0000000000000245. Review.

PMID:
25723615
36.

Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.

Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P.

J Crohns Colitis. 2015 Apr;9(4):305-11. doi: 10.1093/ecco-jcc/jjv031. Epub 2015 Feb 5.

PMID:
25656249
37.

Growth trajectories and bone mineral density in anti-tissue transglutaminase antibody-positive children: the Generation R Study.

Jansen MA, Kiefte-de Jong JC, Gaillard R, Escher JC, Hofman A, Jaddoe VW, Hooijkaas H, Moll HA.

Clin Gastroenterol Hepatol. 2015 May;13(5):913-20.e5. doi: 10.1016/j.cgh.2014.09.032. Epub 2014 Sep 22.

PMID:
25245626
38.

Infant feeding and anti-tissue transglutaminase antibody concentrations in the Generation R Study.

Jansen MA, Tromp II, Kiefte-de Jong JC, Jaddoe VW, Hofman A, Escher JC, Hooijkaas H, Moll HA.

Am J Clin Nutr. 2014 Oct;100(4):1095-101. doi: 10.3945/ajcn.114.090316. Epub 2014 Aug 13.

PMID:
25240074
39.

[Treatment of children with intestinal failure: intestinal rehabilitation, home parenteral nutrition or small intestine transplantation?].

Neelis EG, van Oers HA, Escher JC, Damen GM, Rings EH, Tabbers MM.

Ned Tijdschr Geneeskd. 2014;158:A7771. Review. Dutch.

PMID:
25115209
40.

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.

Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, Amil Dias J, Barabino A, Braegger CP, Bronsky J, Buderus S, Martín-de-Carpi J, De Ridder L, Fagerberg UL, Hugot JP, Kierkus J, Kolacek S, Koletzko S, Lionetti P, Miele E, Navas López VM, Paerregaard A, Russell RK, Serban DE, Shaoul R, Van Rheenen P, Veereman G, Weiss B, Wilson D, Dignass A, Eliakim A, Winter H, Turner D; European Crohn's and Colitis Organisation; European Society of Pediatric Gastroenterology, Hepatology and Nutrition.

J Crohns Colitis. 2014 Oct;8(10):1179-207. doi: 10.1016/j.crohns.2014.04.005. Epub 2014 Jun 6.

41.

Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.

Ruemmele FM, Hyams JS, Otley A, Griffiths A, Kolho KL, Dias JA, Levine A, Escher JC, Taminiau J, Veres G, Colombel JF, Vermeire S, Wilson DC, Turner D.

Gut. 2015 Mar;64(3):438-46. doi: 10.1136/gutjnl-2014-307008. Epub 2014 May 12.

PMID:
24821616
42.

Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function.

Shouval DS, Biswas A, Goettel JA, McCann K, Conaway E, Redhu NS, Mascanfroni ID, Al Adham Z, Lavoie S, Ibourk M, Nguyen DD, Samsom JN, Escher JC, Somech R, Weiss B, Beier R, Conklin LS, Ebens CL, Santos FG, Ferreira AR, Sherlock M, Bhan AK, Müller W, Mora JR, Quintana FJ, Klein C, Muise AM, Horwitz BH, Snapper SB.

Immunity. 2014 May 15;40(5):706-19. doi: 10.1016/j.immuni.2014.03.011. Epub 2014 May 1.

43.

Loss of syntaxin 3 causes variant microvillus inclusion disease.

Wiegerinck CL, Janecke AR, Schneeberger K, Vogel GF, van Haaften-Visser DY, Escher JC, Adam R, Thöni CE, Pfaller K, Jordan AJ, Weis CA, Nijman IJ, Monroe GR, van Hasselt PM, Cutz E, Klumperman J, Clevers H, Nieuwenhuis EE, Houwen RH, van Haaften G, Hess MW, Huber LA, Stapelbroek JM, Müller T, Middendorp S.

Gastroenterology. 2014 Jul;147(1):65-68.e10. doi: 10.1053/j.gastro.2014.04.002. Epub 2014 Apr 12.

PMID:
24726755
44.

Fecal Microbial Transplantation in Early-Onset Colitis: Caution Advised.

Vandenplas Y, Veereman G, van der Werff Ten Bosch J, Goossens A, Pierard D, Samsom JN, Escher JC.

J Pediatr Gastroenterol Nutr. 2015 Sep;61(3):e12-4. doi: 10.1097/MPG.0000000000000281. No abstract available.

PMID:
24399213
45.

Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example.

Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, Escher JC, Kindermann A, Rheenen PF, Berger MY.

BMC Fam Pract. 2013 Nov 25;14:179. doi: 10.1186/1471-2296-14-179.

46.

Gene expression analysis of peripheral cells for subclassification of pediatric inflammatory bowel disease in remission.

van Lierop PP, Swagemakers SM, de Bie CI, Middendorp S, van Baarlen P, Samsom JN, van Ijcken WF, Escher JC, van der Spek PJ, Nieuwenhuis EE.

PLoS One. 2013 Nov 18;8(11):e79549. doi: 10.1371/journal.pone.0079549. eCollection 2013.

47.

ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.

Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho KL, Veres G, Russell RK, Paerregaard A, Buderus S, Greer ML, Dias JA, Veereman-Wauters G, Lionetti P, Sladek M, Martin de Carpi J, Staiano A, Ruemmele FM, Wilson DC; European Society of Pediatric Gastroenterology, Hepatology, and Nutrition.

J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):795-806. doi: 10.1097/MPG.0000000000000239.

PMID:
24231644
48.

Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patients.

van Leeuwen MA, du Pré MF, van Wanrooij RL, de Ruiter LF, Raatgeep HR, Lindenbergh-Kortleve DJ, Mulder CJ, de Ridder L, Escher JC, Samsom JN.

PLoS One. 2013 Jul 12;8(7):e68432. doi: 10.1371/journal.pone.0068432. Print 2013.

49.

Increased production of interleukin-21, but not interleukin-17A, in the small intestine characterizes pediatric celiac disease.

van Leeuwen MA, Lindenbergh-Kortleve DJ, Raatgeep HC, de Ruiter LF, de Krijger RR, Groeneweg M, Escher JC, Samsom JN.

Mucosal Immunol. 2013 Nov;6(6):1202-13. doi: 10.1038/mi.2013.19. Epub 2013 Apr 10.

PMID:
23571506
50.

Enteroscopy in paediatric Crohn's disease.

Di Nardo G, de Ridder L, Oliva S, Casciani E, Escher JC, Cucchiara S.

Dig Liver Dis. 2013 May;45(5):351-5. doi: 10.1016/j.dld.2012.07.020. Epub 2012 Sep 1. Review.

PMID:
22947488

Supplemental Content

Loading ...
Support Center